This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Boston Scientific Corp (BSX)

: Health Care

$21.92
04/29/16 - 4:00:00 PM ET
  • Prev Close: 21.83
  • Avg Vol: 10.29M
  • Shares Outstanding: 1.35B
  • Mkt Cap: 29.43B
  • Div: --
  • Div Yield: --
  • EPS: -0.20
BSX Day's Range
$21.65
$21.96
BSX 52 Week Range
$14.1801
$22.4150
Trade Now:
BSX Business Summary
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg.View BSX key stats
Boston Scientific Corp - BSX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Boston Scientific Corp as a Buy with a ratings score of B.
Report Snippet: We rate BOSTON SCIENTIFIC CORP (BSX) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, revenue growth, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
Rating: 3.67 out of 5, 'B' Buy.
You can view the full analysis from the report here:
BSX Rating Report
BSX Earnings Transcripts
  • BOSTON SCIENTIFIC CORP (BSX) Earnings Report: Q1 2016 Conference Call Transcript
    TheStreet | 04/28/16 - 11:46 AM EDT
  • Boston Scientific (BSX) Earnings Report: Q4 2015 Conference Call Transcript
    TheStreet | 02/07/16 - 05:43 PM EST
  • BOSTON SCIENTIFIC CORP (BSX) Earnings Report: Q3 2015 Conference Call Transcript
    TheStreet | 10/28/15 - 07:02 PM EDT
  • Boston Scientific (BSX) Earnings Report: Q2 2015 Conference Call Transcript
    TheStreet | 07/23/15 - 01:36 PM EDT
BSX EPS Performance
1-Yr Ago
-0.20
2-Yrs Ago
-0.10
3-Yrs Ago
-0.10
BSX Percentage in these ETFs
2.240%
0.240%
0.190%
0.140%
0.060%
BSX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

BSX Boston Scientific Corp

Chart of BSX

Analysts Ratings for BSX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 12 12 11
Moderate Buy 3 3 3 3
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
GET BSX ANALYST REPORT

BSX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs